Abstract
The protective antigen moiety of anthrax toxin translocates the toxin's enzymic moieties to the cytosol of mammalian cells by a mechanism that depends on its ability to heptamerize and insert into membranes. We identified dominant-negative mutants of protective antigen that co-assemble with the wild-type protein and block its ability to translocate the enzymic moieties across membranes. These mutants strongly inhibited toxin action in cell culture and in an animal intoxication model, suggesting that they could be useful in therapy of anthrax.
References
31
Referenced
154
- R. Rapuoli M. Pizza in Cellular Microbiology P. Cossart P. Boquet S. Normark R. Rappuoli Eds. (American Society for Microbiology Press Washington DC 2000) pp. 193–220.
-
Vinion-Dubiel A. D., et al., J. Biol. Chem. 274, 37736 (1999).
(
10.1074/jbc.274.53.37736
) / J. Biol. Chem. by Vinion-Dubiel A. D. (1999) 10.1056/NEJM199909093411107
10.1126/science.280.5364.734
-
Vitale G., et al., Biochem. Biophys. Res. Commun. 248, 706 (1998).
(
10.1006/bbrc.1998.9040
) / Biochem. Biophys. Res. Commun. by Vitale G. (1998) 10.1042/bj3520739
- J. O'Brien
-
Friedlander A., Dreier T., Ezzell J., Leppla S., Infect. Immun. 47, 306 (1985).
(
10.1128/iai.47.1.306-310.1985
) / Infect. Immun. by Friedlander A. (1985) -
Escuyer V., Collier R. J., Infect. Immun. 59, 3381 (1991).
(
10.1128/iai.59.10.3381-3386.1991
) / Infect. Immun. by Escuyer V. (1991) 10.1073/pnas.89.21.10277
10.1038/385833a0
-
Milne J. C., Furlong D., Hanna P. C., Wall J. S., Collier R. J., J. Biol. Chem. 269, 20607 (1994).
(
10.1016/S0021-9258(17)32036-7
) / J. Biol. Chem. by Milne J. C. (1994) - S. H. Leppla in Sourcebook of Bacterial Protein Toxins J. Alouf Ed. (Academic Press New York 1991) pp. 277–302.
-
Elliott J. L., Mogridge J., Collier R. J., Biochemistry 39, 6706 (2000).
(
10.1021/bi000310u
) / Biochemistry by Elliott J. L. (2000) -
Friedlander A. M., J. Biol. Chem. 261, 7123 (1986).
(
10.1016/S0021-9258(17)38364-3
) / J. Biol. Chem. by Friedlander A. M. (1986) -
Koehler T. M., Collier R. J., Mol. Microbiol. 5, 1501 (1991).
(
10.1111/j.1365-2958.1991.tb00796.x
) / Mol. Microbiol. by Koehler T. M. (1991) -
Walker B., Krishnasastry M., Zorn L., Bayley H., J. Biol. Chem. 267, 21782 (1992).
(
10.1016/S0021-9258(19)36680-3
) / J. Biol. Chem. by Walker B. (1992) -
Benson E. L., Huynh P. D., Finkelstein A., Collier R. J., Biochemistry 37, 3941 (1998).
(
10.1021/bi972657b
) / Biochemistry by Benson E. L. (1998) -
Miller C. J., Elliott J. L., Collier R. J., Biochemistry 38, 10432 (1999).
(
10.1021/bi990792d
) / Biochemistry by Miller C. J. (1999) -
Sellman B. R., Nassi S., Collier R. J., J. Biol. Chem. 276, 8371 (2001).
(
10.1074/jbc.M008309200
) / J. Biol. Chem. by Sellman B. R. (2001) - Single-letter abbreviations for the amino acid residues are as follows: A Ala; C Cys; D Asp; E Glu; F Phe; G Gly; H His; I Ile; K Lys; L Leu; M Met; N Asn; P Pro; Q Gln; R Arg; S Ser; T Thr; V Val; W Trp; and Y Tyr.
-
Milne J. C., Blanke S. R., Hanna P. C., Collier R. J., Mol. Microbiol. 15, 661 (1995).
(
10.1111/j.1365-2958.1995.tb02375.x
) / Mol. Microbiol. by Milne J. C. (1995) -
Wesche J., Elliott J. L., Falnes P. O., Olsnes S., Collier R. J., Biochemistry 37, 15737 (1998).
(
10.1021/bi981436i
) / Biochemistry by Wesche J. (1998) -
Beauregard K. E., Collier R. J., Swanson J. A., Cell. Microbiol. 2, 251 (2000).
(
10.1046/j.1462-5822.2000.00052.x
) / Cell. Microbiol. by Beauregard K. E. (2000) - B. R. Sellman M. Mourez R. J. Collier data not shown.
-
Ivins B. E., Ristroph J. D., Nelson G. O., Appl. Environ. Microbiol. 55, 2098 (1989).
(
10.1128/aem.55.8.2098-2100.1989
) / Appl. Environ. Microbiol. by Ivins B. E. (1989) -
Friedlander A. M., Pittman P. R., Parker G. W., JAMA 282, 2104 (1999).
(
10.1001/jama.282.22.2104
) / JAMA by Friedlander A. M. (1999) - PA administered with Ribi Tri-Mix adjuvant elicits an anti-PA response and protects animals from challenge by B. anthracis spores (29). We tested the immunogenicity of the double deletion and F427A mutants by vaccinating groups of six male Fisher 344 rats intramuscularly at 0 3 and 6 weeks with each protein (50 μg) mixed with the Ribi Tri-Mix adjuvant (Sigma) in PBS. The animals were bled prior to the first injection and 14 days following each injection. On day 16 after the final injection the animals were challenged by intravenous injection of a lethal dose of WT-PA plus LF (30 μg + 6 μg respectively). Mock-vaccinated animals became moribund 74 min after injection whereas animals vaccinated with any of the DN mutants or with WT-PA survived without symptoms. Titers of PA-reactive and neutralizing antibodies elicited by the DN mutants (measured after the final injection) were greater than or equal to those elicited by WT-PA.
- Y. Singh H. Kanna A. P. Chopra V. Mehra J. Biol. Chem. in press.
-
McBride B. W., et al., Vaccine 16, 810 (1998).
(
10.1016/S0264-410X(97)00268-5
) / Vaccine by McBride B. W. (1998) - Supported by grant R37-AI22021 (R.J.C.) and training grant 5T32AI07410 (B.R.S.) from the NIH DSP/DGA (9860830006) (M.M.) and the Fondation Philippe (M.M.). R.J.C. has financial interest in AVANT Immunotherapeutics Inc.
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 27, 2002, 5:52 a.m.) |
Deposited | 1 year, 7 months ago (Jan. 9, 2024, 11:26 p.m.) |
Indexed | 4 months, 3 weeks ago (April 10, 2025, 8:29 a.m.) |
Issued | 24 years, 4 months ago (April 27, 2001) |
Published | 24 years, 4 months ago (April 27, 2001) |
Published Print | 24 years, 4 months ago (April 27, 2001) |
@article{Sellman_2001, title={Dominant-Negative Mutants of a Toxin Subunit: An Approach to Therapy of Anthrax}, volume={292}, ISSN={1095-9203}, url={http://dx.doi.org/10.1126/science.109563}, DOI={10.1126/science.109563}, number={5517}, journal={Science}, publisher={American Association for the Advancement of Science (AAAS)}, author={Sellman, Bret R. and Mourez, Michael and John Collier, R.}, year={2001}, month=apr, pages={695–697} }